A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.

Français
Author : 
Fizazi, K ; Delva, R ; Caty, A ; Chevreau, C ; Kerbrat, P ; Rolland, F & al
Newspaper edition : 
Eur. Urol. - Année 2014 - Volume 65 - Page 381-6 - PMID 24094847